603 days ago
These chaps are two pillars of the establishment. Gent has been CEO of Vodafone (VOD) and Chairman of GSK (GSK). Clarke has been running companies including Majestic Wine since he stopped being a CSFB bankster in the early nineties. And he went to Rugby and Oxford so is a true scholar and a gentleman. Okay, Eales is a relative oik.
611 days ago
I start with a bity of my travel adventures. I was in bed by 3 AM last night after the previous night’s 5 AM. If I ever say that I am driving from Greece to Wales in 2.5 days again you can shoot me. Then I remind you that it is less than a month to ShareStock so book your seats on the greenest lawn in Wales NOW. Then I look in detail at Revolution Beauty (REVB), Wildcat Petroleum (WCAT), I have a hot rumour on Parsley Box (MEAL) and I comment on GSK (GSK) and the Zantac issue. or non issue. Any more carcinogens with your medication vicar?
613 days ago
I shall post photos in the next day or so showing me climbing a rocky and overgrown hill to a castle in the burning midday sun with my daughter Jaya on my back. I did the same three years ago with Joshua but managed better today. There is still life in this old dog. Then onto GSK (GSK) and Haleon (HLN). I ditched my Haleon shares today and explain why. Then I look at Revolution Beauty (REVB), ProCook (PROC), the fraud Supply@ME Capital (SYME), Cellular Goods (CBX) and in detail at Purplebricks (PURP).
622 days ago
GSK plc (GSK) has announced a “slightly better than expected” first-half performance, and the shares have responded up to 1755.8p.
713 days ago
GlaxoSmithKline (GSK) has announced its first quarter of the year results and that it reconfirms its full-year 2022 guidance. We are well ahead on this share tip where we are also drinking our own medicine so what to do now?
989 days ago
GlaxoSmithKline (GSK) has announced second quarter of the year results, including stating “strong commercial execution” and “we are likely to deliver full-year Adjusted EPS towards the better end of our guidance range”. So where now for the shares?, with they currently having responded back up to 1400p.
1013 days ago
Joshua and I are about to have pancakes and a swim and then set out on the next leg of our road trip. A few photos from yesterday’s tearful encounters are HERE. In today’s podcast, I look at the smears that establishment folk like Alex Brummer are using to defend an establishment woman who has failed to deliver, the grotesquely overpaid CEO of GlaxoSmithKline (GSK) Emma Walmsley. I want her to pack her bags too and explain why she should.
1029 days ago
In today’s bearcast I consider Verditek (VDTK), GlaxoSmithKline (GSK), Sosandar (oink, oink) First Property (FPO) , Remote Monitored Systems (RMS) and MyHealthChecked (MHC).
1079 days ago
I discuss Abi the teenage curtain twitcher snitching on me HERE and also my training walk today. Please, please, please do donate to Rogue Bloggers for Woodlarks HERE. Then into Versarien (VRS), Glaxo SmithKline (GSK), executive greed and ESG nonsense.
1878 days ago
In today's bearcast I digress with some Booker family geneology but I discuss blue chip yield plays including Glaxo SmithKline (GSK) but then real estate plays such as British Land (BLND) and finally the housebuilders notably Persimmon (PSN) and Crest Nicholson (CRST). Then I look at the scandal that is Mercantile Ports (MPL), TekCapital (TEK) and finally, in some detail, Amur Minerals (AMC).
2663 days ago
You want your share tip of the year to have the potential to double or treble. You will not get that with GlaxoSmithKline (GSK). Equally it is incredibly unlikely that you might lose 75% of your cash on Glaxo. Elephants do not gallop eith forwards or backwards. My third tip of the year is a stock that could lose 75% and become a cash shell. But it is also one that could easily treble and I think he odds are on the treble not the collapse. I refer to Wishbone Gold (WSBN)
